Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name LY3537982
Trade Name
Synonyms LY 3537982|LY-3537982
Drug Descriptions

LY3537982 selectively inhibits KRAS G12C, potentially leading to growth inhibition of KRAS G12C-expressing tumor cells (Cancer Res 2021;81(13_Suppl):Abstract nr 1259).

DrugClasses KRAS G12C inhibitor 16
CAS Registry Number NA
NCIT ID NA

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Abemaciclib + LY3537982 Abemaciclib LY3537982 0 1
Cetuximab + LY3537982 Cetuximab LY3537982 0 1
Erlotinib + LY3537982 Erlotinib LY3537982 0 1
LY3214996 + LY3537982 LY3214996 LY3537982 0 1
LY3295668 + LY3537982 LY3295668 LY3537982 0 1
LY3537982 LY3537982 0 1
LY3537982 + Sintilimab LY3537982 Sintilimab 0 1


Additional content available in CKB BOOST